IBO’s company of the year for 2021 is Thermo Fisher Scientific. During 2021, Thermo Fisher balanced the demands of recent and pending major acquisitions (see IBO 4/16/21), the unpredictable COVID-19 marketplace, the roll out of multiple new products and a commitment to the fundamentals of its business strategy. IBO selects a company of the year […]
As publicly traded companies that participate in the laboratory instrumentation space begin to release their annual reports, the SDi team of expert analysts is hard at work compiling data to prepare the highly anticipated 2022 edition of our flagship annual report, the SDi Global Assessment Report. As always, we strive to provide the gold standard […]
Implementing the appropriate laboratory instrumentation to support therapeutic development is crucial to the process of drug discovery. Life science and analytical instrumentation facilitates pharmaceutical R&D throughout these stages. SDi has observed the dynamics of the pharma/bio sector demand for instrumentation to support innovative biologics, small molecule drugs, regenerative pharmaceuticals, and biopharmaceuticals. Most of these drug […]
The servicing of analytical and life science instrumentation is vital to maintaining instrument performance capabilities and maximizing the life of costly lab assets. Whether provided by the original instrument manufacturer or by a third-party service provider, the instrument service market includes all service contracts and any replacement parts installed during servicing. Other services like software […]
Clinical laboratory diagnostics has become an important area of investment and business transactions. Recently, Mesa Laboratories, a biotech company focused on quality control solutions for pharmaceutical, healthcare, and medical devices, announced the acquisition of Agena Bioscience for a cash purchase price of $300 million. According to the press release, Mesa is expected to pay for […]
While M&A and IPO activity tends to ebb and flow in the laboratory industry, the current trend seems to be on the upswing. Just over the past few weeks, there seems to be a hotbed of activity particularly in the area of laboratory consumables. Most notably, near the end of July, PerkinElmer announced a $5.25 […]
Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, with promising developments expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others as well. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge […]
Testing has been at the forefront of public health efforts and challenges since the beginning of the pandemic caused by SARS-CoV-2, the virus responsible for COVID-19 disease. By April last year, it became increasingly clear that testing would be crucial to public health and safety. However, global testing capacities substantially lagged behind demand as shortages […]
This month marked the anniversary of the World Health Organization’s declaration of the SARS-CoV-2 outbreak as a pandemic. Virtually all aspects of normal life and business were quickly disrupted by the novel and deadly coronavirus as it spread across the world. But researchers and the analytical instrumentation companies that supply them rose to the occasion. […]
Instrument Business Outlook estimates the Analytical Instruments and Lab Products Industry is expected to grow at 9.4% in 2021. Is your business best positioned to take advantage of opportunities in this massive market? That’s the results from the 2021 IBO Annual Review and Industry Forecast Issue as an accurate source for predictions, news, and information […]
